A cost analysis of fondaparinux versus enoxaparin in total knee arthroplasty.

American journal of therapeutics

Volumn 11, Issue 1, 2004, Pages 3-8

  Spruill, William J ^a   Wade, William E ^a   Leslie, Ryan B ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; POLYSACCHARIDE;

AGED; ARTICLE; COMPARATIVE STUDY; COST; DRUG COST; ECONOMICS; FEMALE; HUMAN; KNEE ARTHROPLASTY; MALE; POSTOPERATIVE COMPLICATION; VEIN THROMBOSIS;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; COSTS AND COST ANALYSIS; DRUG COSTS; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

EID: 2342522111     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200401000-00004     Document Type: Article

References (0)